Post-Essential Thrombocytopenia
1 clinical trials · Condition
◉ Watch Post-Essential Thrombocytopenia
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis (NCT00931762) | Novartis Pharmaceuticals | 2009-08-31 |
Track Post-Essential Thrombocytopenia automatically
Every clearance here is in the API, with alerts when new ones post.